Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, With Dapagliflozin and Ipragliflozin

Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics12030268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2013English

The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Protective Effects of Ipragliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, on a Non-Alcoholic Steatohepatitis Mouse Model

Yonago Acta Medica
Medicine
2019English

Clinical Risk Factors Predicting Genital Fungal Infections With Sodium–glucose Cotransporter 2 Inhibitor Treatment: The ABCD Nationwide Dapagliflozin Audit

Primary Care Diabetes
Internal MedicineNutritionEndocrinologyDieteticsMetabolismDiabetes
2018English

Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis

European Scientific Journal ESJ
2019English

In Vitro Pharmacological Profile of Ipragliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2019English

Pharmacokinetics and Pharmacodynamics of a Novel Acetylcholinesterase Inhibitor, DMNG-3

Acta Neurobiologiae Experimentalis
MedicineNeuroscience
2016English

Increased Grip Strength With Sodium-Glucose Cotransporter 2

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2016English

Ertugliflozin: A Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes

Therapeutics and Clinical Risk Management
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy